The main component of the device system; the other relevant components include: product id: 8781, serial (b)(4), implanted: (b)(6) 2015, explanted: (b)(6) 2018, product type: catheter.
If information is provided in the future, a supplemental report will be issued.
|
Information was received from a healthcare provider (hcp) via a manufacturer representative on 2018-feb-20 regarding a patient receiving fentanyl (1291 mcg/ml at 199 mcg/day), bupivacaine (20 mg/ml at 3 mg/day), and dilaudid (0.
9 mg/ml at 0.
139 mg/day) via an implanted infusion pump.
The indication for use was non-malignant pain.
Other medications the patient was taking at the time of the event included amoxicillin, baclofen, cymbalta, pepcid, neurontin, synthroid, ativan, magog, imodium, prevalite, mycostatin, oxycodone, desyrel, bactrim, and claritin.
The patient's medical history included paraplegic status, diabetes mellitus (dm), osteoporosis, decubitus ulcer, colostomy, "hz dvts," pyelonephritis, septic shock, urinary tract infections (utis) with sepsis, hypothyroidism, urostomy, metabolic encephalopathy, and acute renal failure.
It was reported that the patient was having increased pain on an unknown date.
A catheter dye study was done on (b)(6) 2018, but failed as the hcp was unable to aspirate the catheter.
Surgery occurred on (b)(6) 2018 and the catheter was found to be kinked near the anchor.
The catheter was cut above the kink and the hcp was able to aspirate cerebrospinal fluid (csf).
The flow was sluggish, so the spinal segment was replaced.
The issue was considered resolved and the patient's status at the time of report was alive - no injury.
No further complications were reported or anticipated.
|
Refers to the main device, the other relevant component includes: product id 8781 (b)(4) implanted: (b)(6)2015 explanted: (b)(6)2018; product type catheter; ubd: (b)(4)2017; (b)(6).
Of note, only the catheter was returned for analysis.
Evaluation of implantable catheter (b)(4) revealed no significant anomalies.
However, only a small segment of the catheter was returned for analysis.
Analysis identified melting damage on the catheter consistent with explant damage.
Device code (b)(4) has been added.
The evaluation codes have also been updated.
If information is provided in the future, a supplemental report will be issued.
|